Skip to Content
Merck
CN
  • Absence of loss of heterozygosity of BRCA1 in a renal tumor from a BRCA1 germline mutation carrier.

Absence of loss of heterozygosity of BRCA1 in a renal tumor from a BRCA1 germline mutation carrier.

Familial cancer (2012-10-23)
Shaheen Alanee, Sohela Shah, Rajmohan Murali, Rohini Rau-Murthy, Kasmintan A Schrader, Kenneth Offit
ABSTRACT

BRCA1 functions as a tumor suppressor gene and germline and somatic mutations in this gene have been shown to be associated with many types of cancer. We report the first tumor study of renal cell carcinoma in a carrier of the deleterious BRCA1 mutation-c.68_69delAG.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-BRCA1 (Ab-1) Mouse mAb (MS110), liquid, clone MS110, Calbiochem®